NO742345L - - Google Patents
Info
- Publication number
- NO742345L NO742345L NO742345A NO742345A NO742345L NO 742345 L NO742345 L NO 742345L NO 742345 A NO742345 A NO 742345A NO 742345 A NO742345 A NO 742345A NO 742345 L NO742345 L NO 742345L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- formula
- group
- mol
- carried out
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 106
- 238000000034 method Methods 0.000 claims description 47
- -1 alkaline earth metal salts Chemical class 0.000 claims description 40
- 239000002253 acid Chemical group 0.000 claims description 39
- 229910052783 alkali metal Inorganic materials 0.000 claims description 39
- 150000001340 alkali metals Chemical class 0.000 claims description 39
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 39
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 239000003574 free electron Substances 0.000 claims description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 7
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical group [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
- 238000007278 cyanoethylation reaction Methods 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 238000006477 desulfuration reaction Methods 0.000 claims description 3
- 230000023556 desulfurization Effects 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012312 sodium hydride Substances 0.000 claims description 3
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 125000003172 aldehyde group Chemical group 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000007868 Raney catalyst Substances 0.000 claims 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims 1
- 229910000564 Raney nickel Inorganic materials 0.000 claims 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- 238000002844 melting Methods 0.000 description 26
- 230000008018 melting Effects 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- 239000002244 precipitate Substances 0.000 description 17
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 239000007858 starting material Substances 0.000 description 14
- 238000010992 reflux Methods 0.000 description 13
- 238000001816 cooling Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 10
- 238000004809 thin layer chromatography Methods 0.000 description 10
- 238000004448 titration Methods 0.000 description 10
- 159000000000 sodium salts Chemical class 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- AQQVZSSDVVBDEI-UHFFFAOYSA-N 2-[4,5-bis(4-methoxyphenyl)-2-propan-2-ylimidazol-1-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=CC(OC)=CC=2)N(CC(O)=O)C(C(C)C)=N1 AQQVZSSDVVBDEI-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- OVXOOEYIVCXYDQ-UHFFFAOYSA-N 2-(2,4,5-triphenylimidazol-1-yl)acetic acid Chemical compound OC(=O)CN1C(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OVXOOEYIVCXYDQ-UHFFFAOYSA-N 0.000 description 3
- DOPDKEZFZKFWRE-UHFFFAOYSA-N 2-(4,5-diphenylimidazol-1-yl)propanoic acid Chemical compound OC(=O)C(C)N1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 DOPDKEZFZKFWRE-UHFFFAOYSA-N 0.000 description 3
- XGRCEWOESINNAL-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)-4,5-diphenylimidazol-1-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1C(N1CC(O)=O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 XGRCEWOESINNAL-UHFFFAOYSA-N 0.000 description 3
- VZUFIYIPPDCMNR-UHFFFAOYSA-N 3-(4,5-diphenyl-2-propan-2-ylimidazol-1-yl)propanoic acid Chemical compound OC(=O)CCN1C(C(C)C)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 VZUFIYIPPDCMNR-UHFFFAOYSA-N 0.000 description 3
- IDEXSXXOOIBEED-UHFFFAOYSA-N 3-[2-(4-chlorophenyl)-3-oxido-4,5-diphenylimidazol-3-ium-1-yl]propanoic acid Chemical compound [O-][N+]1=C(C=2C=CC(Cl)=CC=2)N(CCC(=O)O)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 IDEXSXXOOIBEED-UHFFFAOYSA-N 0.000 description 3
- XZIWNWLMRPLQGZ-UHFFFAOYSA-N 3-[2-(4-chlorophenyl)-4,5-diphenylimidazol-1-yl]propanoic acid Chemical compound OC(=O)CCN1C(C=2C=CC(Cl)=CC=2)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 XZIWNWLMRPLQGZ-UHFFFAOYSA-N 0.000 description 3
- OEWSJXJEVZOJBD-UHFFFAOYSA-N 3-[2-(4-methylphenyl)-3-oxido-4,5-diphenylimidazol-3-ium-1-yl]propanoic acid Chemical compound C1=CC(C)=CC=C1C1=[N+]([O-])C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1CCC(O)=O OEWSJXJEVZOJBD-UHFFFAOYSA-N 0.000 description 3
- YYJQFAWECULULG-UHFFFAOYSA-N 3-[4,5-bis(4-methoxyphenyl)-2-propan-2-ylimidazol-1-yl]propanoic acid Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=CC(OC)=CC=2)N(CCC(O)=O)C(C(C)C)=N1 YYJQFAWECULULG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- DWDVMFNDNUTALS-UHFFFAOYSA-N 2-(2,4,5-triphenylimidazol-1-yl)propanoic acid Chemical compound OC(=O)C(C)N1C(C=2C=CC=CC=2)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 DWDVMFNDNUTALS-UHFFFAOYSA-N 0.000 description 2
- RWVAZZIVOQSNKW-UHFFFAOYSA-N 2-(3-oxido-2,4,5-triphenylimidazol-3-ium-1-yl)propanoic acid Chemical compound [O-][N+]1=C(C=2C=CC=CC=2)N(C(C(O)=O)C)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 RWVAZZIVOQSNKW-UHFFFAOYSA-N 0.000 description 2
- UFTBOKJDSUBCER-UHFFFAOYSA-N 2-(4,5-diphenylimidazol-1-yl)acetic acid Chemical compound OC(=O)CN1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 UFTBOKJDSUBCER-UHFFFAOYSA-N 0.000 description 2
- XZQAEMCOSPEEJI-UHFFFAOYSA-N 2-[2-(4-nitrophenyl)-3-oxido-4,5-diphenylimidazol-3-ium-1-yl]acetic acid Chemical compound [O-][N+]1=C(C=2C=CC(=CC=2)[N+]([O-])=O)N(CC(=O)O)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 XZQAEMCOSPEEJI-UHFFFAOYSA-N 0.000 description 2
- JNPQNAZIHLCZRN-UHFFFAOYSA-N 3-(2-cyclohexyl-3-oxido-4,5-diphenylimidazol-3-ium-1-yl)propanoic acid Chemical compound [O-][N+]=1C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N(CCC(=O)O)C=1C1CCCCC1 JNPQNAZIHLCZRN-UHFFFAOYSA-N 0.000 description 2
- XFYBIISBDQETCU-UHFFFAOYSA-N 3-(4,5-diphenyl-2-propan-2-ylimidazol-1-yl)propanoic acid;hydrochloride Chemical compound Cl.OC(=O)CCN1C(C(C)C)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 XFYBIISBDQETCU-UHFFFAOYSA-N 0.000 description 2
- PMPYALPNHUIRKE-UHFFFAOYSA-N 3-[2-(4-chlorophenyl)-5-methyl-3-oxido-4-phenylimidazol-3-ium-1-yl]propanoic acid Chemical compound [O-][N+]1=C(C=2C=CC(Cl)=CC=2)N(CCC(O)=O)C(C)=C1C1=CC=CC=C1 PMPYALPNHUIRKE-UHFFFAOYSA-N 0.000 description 2
- JQHMGJGPYBKCQV-UHFFFAOYSA-N 3-[2-(4-methoxyphenyl)-3-oxido-4,5-diphenylimidazol-3-ium-1-yl]propanoic acid Chemical compound C1=CC(OC)=CC=C1C1=[N+]([O-])C(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1CCC(O)=O JQHMGJGPYBKCQV-UHFFFAOYSA-N 0.000 description 2
- GCPFZFVPYUDFQR-UHFFFAOYSA-N 3-[2-(4-methoxyphenyl)-4,5-diphenylimidazol-1-yl]propanoic acid Chemical compound C1=CC(OC)=CC=C1C(N1CCC(O)=O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 GCPFZFVPYUDFQR-UHFFFAOYSA-N 0.000 description 2
- CPHGOBGXZQKCKI-UHFFFAOYSA-N 4,5-diphenyl-1h-imidazole Chemical compound N1C=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 CPHGOBGXZQKCKI-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- ZAULAJOXYCKAES-UHFFFAOYSA-N [O-][N+]=1C=CNC=1 Chemical compound [O-][N+]=1C=CNC=1 ZAULAJOXYCKAES-UHFFFAOYSA-N 0.000 description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- YQHWURFNAULYNW-UHFFFAOYSA-N 1-hydroxyimino-1-phenylpropan-2-one Chemical compound CC(=O)C(=NO)C1=CC=CC=C1 YQHWURFNAULYNW-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
- YSFBEAASFUWWHU-UHFFFAOYSA-N 2,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C(Cl)=C1 YSFBEAASFUWWHU-UHFFFAOYSA-N 0.000 description 1
- NJXBHEMXPUMJRO-UHFFFAOYSA-N 2-(4-chlorophenyl)-4,5-diphenyl-1h-imidazole Chemical compound C1=CC(Cl)=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 NJXBHEMXPUMJRO-UHFFFAOYSA-N 0.000 description 1
- SNFCQJAJPFWBDJ-UHFFFAOYSA-N 2-(4-methoxyphenyl)-4,5-diphenyl-1h-imidazole Chemical compound C1=CC(OC)=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 SNFCQJAJPFWBDJ-UHFFFAOYSA-N 0.000 description 1
- FJXHGBDQXPZXCH-UHFFFAOYSA-N 2-[4,5-bis(4-methoxyphenyl)-3-oxido-2-propan-2-ylimidazol-3-ium-1-yl]acetic acid Chemical compound C1=CC(OC)=CC=C1C(N(C(C(C)C)=[N+]1[O-])CC(O)=O)=C1C1=CC=C(OC)C=C1 FJXHGBDQXPZXCH-UHFFFAOYSA-N 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- MEXFTYYURGLCMJ-UHFFFAOYSA-N 3-(3-oxido-4,5-diphenyl-2-propan-2-ylimidazol-3-ium-1-yl)propanoic acid Chemical compound [O-][N+]1=C(C(C)C)N(CCC(O)=O)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 MEXFTYYURGLCMJ-UHFFFAOYSA-N 0.000 description 1
- YSXLJEHDZQQVES-UHFFFAOYSA-N 3-[2-(3-chlorophenyl)-3-oxido-4,5-diphenylimidazol-3-ium-1-yl]propanoic acid Chemical compound [O-][N+]1=C(C=2C=C(Cl)C=CC=2)N(CCC(=O)O)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 YSXLJEHDZQQVES-UHFFFAOYSA-N 0.000 description 1
- TUAUTQWGOQPMBJ-UHFFFAOYSA-N 3-[2-(4-chlorophenyl)-4,5-bis(4-methoxyphenyl)imidazol-1-yl]propanoic acid Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=CC(OC)=CC=2)N(CCC(O)=O)C(C=2C=CC(Cl)=CC=2)=N1 TUAUTQWGOQPMBJ-UHFFFAOYSA-N 0.000 description 1
- QUSCRGYPROAZFS-UHFFFAOYSA-N 3-[2-(4-chlorophenyl)-4-methyl-3-oxido-5-phenylimidazol-3-ium-1-yl]propanoic acid Chemical compound OC(=O)CCN1C(C=2C=CC(Cl)=CC=2)=[N+]([O-])C(C)=C1C1=CC=CC=C1 QUSCRGYPROAZFS-UHFFFAOYSA-N 0.000 description 1
- YCMHFCPVVFQHRV-UHFFFAOYSA-N 3-[2-ethyl-4,5-bis(4-methoxyphenyl)-3-oxidoimidazol-3-ium-1-yl]propanoic acid Chemical compound [O-][N+]1=C(CC)N(CCC(O)=O)C(C=2C=CC(OC)=CC=2)=C1C1=CC=C(OC)C=C1 YCMHFCPVVFQHRV-UHFFFAOYSA-N 0.000 description 1
- DAEVDOTXPHFDDJ-UHFFFAOYSA-N 3-[4,5-bis(4-methoxyphenyl)-3-oxido-2-propan-2-ylimidazol-3-ium-1-yl]propanoic acid Chemical compound C1=CC(OC)=CC=C1C(N(C(C(C)C)=[N+]1[O-])CCC(O)=O)=C1C1=CC=C(OC)C=C1 DAEVDOTXPHFDDJ-UHFFFAOYSA-N 0.000 description 1
- BUPXDXGYFXDDAA-UHFFFAOYSA-N 3-bromo-2-methylpropanoic acid Chemical compound BrCC(C)C(O)=O BUPXDXGYFXDDAA-UHFFFAOYSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- DHJPQGYNAQBXPM-UHFFFAOYSA-N 4,5-bis(4-methoxyphenyl)-2-propan-2-yl-1h-imidazole Chemical compound C1=CC(OC)=CC=C1C1=C(C=2C=CC(OC)=CC=2)NC(C(C)C)=N1 DHJPQGYNAQBXPM-UHFFFAOYSA-N 0.000 description 1
- KDPMUOQKEHXSOI-UHFFFAOYSA-N 4,5-diphenyl-2-propan-2-yl-1h-imidazole Chemical compound N1C(C(C)C)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 KDPMUOQKEHXSOI-UHFFFAOYSA-N 0.000 description 1
- FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical class C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 1
- CTGCNVDBEQHVOK-UHFFFAOYSA-N C(=O)(O)CN1C=NC(=C1C1=CC=CC=C1)C1=CC=CC=C1.[Na] Chemical compound C(=O)(O)CN1C=NC(=C1C1=CC=CC=C1)C1=CC=CC=C1.[Na] CTGCNVDBEQHVOK-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3083073A GB1469532A (en) | 1973-06-28 | 1973-06-28 | Imimdazolyl-alkanoic acid derivatives |
| GB2363674 | 1974-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO742345L true NO742345L (xx) | 1975-01-27 |
Family
ID=26256639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO742345A NO742345L (xx) | 1973-06-28 | 1974-06-27 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3952005A (xx) |
| JP (1) | JPS5069079A (xx) |
| CH (1) | CH605803A5 (xx) |
| DE (1) | DE2430978A1 (xx) |
| DK (1) | DK345874A (xx) |
| FI (1) | FI199574A (xx) |
| FR (1) | FR2234895B1 (xx) |
| HU (1) | HU172227B (xx) |
| NL (1) | NL7408708A (xx) |
| NO (1) | NO742345L (xx) |
| SE (1) | SE7408520L (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314844A (en) * | 1979-01-11 | 1982-02-09 | Rohm And Haas Company | Herbicidal substituted imidazoles |
| DE3222220A1 (de) * | 1982-06-12 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Azolylmethyl-ketone, verfahren zu ihrer herstellung und ihre verwendung als zwischenprodukte |
| JPH03145473A (ja) * | 1989-10-27 | 1991-06-20 | Hisamitsu Pharmaceut Co Inc | 新規なイミダゾール酢酸誘導体 |
| JP5610751B2 (ja) * | 2008-12-02 | 2014-10-22 | 日本合成化学工業株式会社 | 金属表面処理剤ならびにイミダゾール系化合物 |
| US11939298B1 (en) | 2023-10-25 | 2024-03-26 | King Faisal University | 5-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound |
| US11912665B1 (en) * | 2023-10-25 | 2024-02-27 | King Faisal University | 4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid as an antimicrobial compound |
| US11945783B1 (en) | 2023-10-26 | 2024-04-02 | King Faisal University | 4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)butanoic acid as an antimicrobial compound |
| US11932607B1 (en) | 2023-10-27 | 2024-03-19 | King Faisal University | 4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)benzoic acid as an antimicrobial compound |
| US11957663B1 (en) | 2023-10-31 | 2024-04-16 | King Faisal University | 3-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl) propanoic acid as an antimicrobial compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1458080A (fr) * | 1963-10-23 | 1966-03-04 | Ciba Geigy | Nouveaux imidazoles et procédé pour leur préparation |
| US3351628A (en) * | 1963-10-23 | 1967-11-07 | Ciba Geigy Corp | 1-ethyl-4, 5-di-(para-methoxyphenyl)-imidazole and a salt thereof |
| FR1475153A (fr) * | 1965-04-09 | 1967-03-31 | Hoffmann La Roche | Procédé pour la préparation de dérivés d'imidazole |
| FR1520920A (fr) * | 1966-04-18 | 1968-04-12 | Hoffmann La Roche | Procédé pour la préparation de dérivés d'imidazole |
| FR1538154A (fr) * | 1967-09-26 | 1968-08-30 | Nouveaux dérivés du 4, 5-diphénylimidazole | |
| CH524612A (de) * | 1969-12-31 | 1972-06-30 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Imidazolderivaten |
-
1974
- 1974-06-27 FR FR7422432A patent/FR2234895B1/fr not_active Expired
- 1974-06-27 NL NL7408708A patent/NL7408708A/xx unknown
- 1974-06-27 NO NO742345A patent/NO742345L/no unknown
- 1974-06-27 JP JP49073781A patent/JPS5069079A/ja active Pending
- 1974-06-27 FI FI1995/74A patent/FI199574A/fi unknown
- 1974-06-27 CH CH887674A patent/CH605803A5/xx not_active IP Right Cessation
- 1974-06-27 DK DK345874A patent/DK345874A/da not_active Application Discontinuation
- 1974-06-27 DE DE2430978A patent/DE2430978A1/de active Pending
- 1974-06-27 SE SE7408520A patent/SE7408520L/xx unknown
- 1974-06-27 US US05/483,826 patent/US3952005A/en not_active Expired - Lifetime
- 1974-06-27 HU HU74DU00000223A patent/HU172227B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7052374A (en) | 1976-01-08 |
| US3952005A (en) | 1976-04-20 |
| DK345874A (xx) | 1975-02-24 |
| SE7408520L (xx) | 1974-12-30 |
| FR2234895A1 (xx) | 1975-01-24 |
| NL7408708A (xx) | 1974-12-31 |
| JPS5069079A (xx) | 1975-06-09 |
| HU172227B (hu) | 1978-07-28 |
| CH605803A5 (xx) | 1978-10-13 |
| FI199574A (xx) | 1974-12-29 |
| DE2430978A1 (de) | 1975-01-23 |
| FR2234895B1 (xx) | 1978-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1152515A (en) | Imidazole derivatives, their production and use | |
| SU1535379A3 (ru) | Способ получени 5-замещенных 2,4-диаминопиримидинов или их кислотно-аддитивных солей | |
| NO151966B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater | |
| HU187773B (en) | Process for preparing substituted imidazole derivatives maceutical compositions containing such compounds | |
| HU189738B (en) | Process for preparing intermediary compounds of omeprazole | |
| SU659081A3 (ru) | Способ получени фенилэтиламинов или их солей | |
| NO742345L (xx) | ||
| IE47139B1 (en) | 4-substituted-pyrazoles | |
| US4910212A (en) | Heterocyclic compounds | |
| WO2000062782A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
| FI91858B (fi) | Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja | |
| HU200447B (en) | Process for production of 1-alkyl-5-nitro-imidasoles | |
| SU497772A3 (ru) | Способ получени замещенных 2-фениламино-имидазолинов-(2) | |
| NO123529B (no) | Fremgangsmate ved fremstilling av 1-substituerte 5-nitroimidazol-2-ylalkyl-carbamater | |
| SU609465A3 (ru) | Способ получени проивзодных бензилпиримидина или их солей | |
| CS208463B2 (en) | Method of making the 4-/n-acetyl/amino-tetrahydro-1,3,5-triazine-2,6-dions | |
| JPS62273959A (ja) | イミダゾリウム化合物 | |
| NO126624B (xx) | ||
| CN112661668A (zh) | 一种n-取代酰胺类化合物及其制备方法 | |
| NO763876L (xx) | ||
| NO133230B (xx) | ||
| NO128570B (xx) | ||
| US9611217B2 (en) | Synthetic processes of carprofen | |
| DK141066B (da) | Analogifremgangsmåde til fremstilling af aminoimidazokinolinderivater. | |
| US3644392A (en) | 1-substituted-5-nitroimidazole-2-carboximidates |